KDMs | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

36 results for “KDMs”

Trials

View all 18 →

PDMS Outcome After Intensive Care, Organdysfunction and Monitoring

6,909 participants · First posted Dec 20, 2017

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

60 participants · First posted Jun 18, 2009

IIT PH1 KDS-1001 in Patients With CML

12 participants · First posted Mar 22, 2021

Drugs

View all 12 →

KDS-12017

KDS-1001

KDM-1104

Organizations

KIMS HOSPITAL

India

KIMS HEALTH CARE MANAGEMENT LIMITED

India

News

Telomir-1 Demonstrates Selective Killing of Triple-Negative Breast Cancer Cells Through Iron-Dependent Mechanism

Phase 3 Trial of India's First Indigenous Dengue Vaccine, 'DengiAll,' Commences

Apollo Hospital and KIMS-Sunshine Partner with Medtronic to Launch Renal Denervation Therapy Centers for Resistant Hypertension

Page 1 of 4